The latest price target for Agilon Health (NYSE:AGL) was reported by RBC Capital on February 26, 2025. The analyst firm set a price target for $3.50 expecting AGL to fall to within 12 months (a possible -2.78% downside). 28 analyst firms have reported ratings in the last year.

The latest analyst rating for Agilon Health (NYSE:AGL) was provided by RBC Capital, and Agilon Health maintained their outperform rating.

The last upgrade for Agilon Health Inc happened on January 10, 2025 when Citigroup raised their price target to $2.25. Citigroup previously had a sell for Agilon Health Inc.

The last downgrade for Agilon Health Inc happened on November 11, 2024 when JMP Securities changed their price target from N/A to N/A for Agilon Health Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Agilon Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Agilon Health was filed on February 26, 2025 so you should expect the next rating to be made available sometime around February 26, 2026.

While ratings are subjective and will change, the latest Agilon Health (AGL) rating was a maintained with a price target of $3.00 to $3.50. The current price Agilon Health (AGL) is trading at is $3.60, which is out of the analyst’s predicted range.